ArrowMark Colorado Holdings’s Clovis Oncology, Inc. CLVS Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-79,635	Closed	-$7.32M	–	285
2015 Q3	$7.32M	Sell	79,635 -50	-0.1%	-$4.33K	0.2%	121
2015 Q2	$7M	Sell	79,685 -201,161	-72%	-$17.2M	0.17%	124
2015 Q1	$20.8M	Sell	280,846 -132,011	-32%	-$9.32M	0.54%	65
2014 Q4	$23.1M	Buy	412,857 +21,711	+6%	+$1.14M	0.59%	55
2014 Q3	$17.7M	Sell	391,146 -8,283	-2%	-$346K	0.49%	65
2014 Q2	$16.5M	Buy	399,429 +129,631	+48%	+$6.68M	0.47%	77
2014 Q1	$18.7M	Sell	269,798 -41,334	-13%	-$3.04M	0.61%	61
2013 Q4	$18.8M	Buy	311,132 +66,046	+27%	+$3.59M	0.58%	62
2013 Q3	$14.9M	Buy	245,086 +134,596	+122%	+$9.55M	0.49%	74
2013 Q2	$7.4M	Buy	+110,490	New	+$4.97M	1.99%	13

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ArrowMark Colorado Holdings's CLVS Position: Q4 2015 in Review

ArrowMark Colorado Holdings sold out of Clovis Oncology, Inc. (CLVS) in Q4 2015, closing a stake of 79,635 shares — an estimated $7.32M sold.

ArrowMark Colorado Holdings first reported a position in CLVS in Q2 2013 and held it in 10 quarters. The position peaked at $23.1M in Q4 2014. 157 funds tracked by Wall St. Rank hold CLVS as of Q4 2015.

ArrowMark Colorado Holdings reported no remaining Clovis Oncology, Inc. position as of Q4 2015 after selling out during the quarter.
ArrowMark Colorado Holdings sold 79,635 Clovis Oncology, Inc. shares in Q4 2015, an estimated $7.32M.
ArrowMark Colorado Holdings first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 10 quarters.
ArrowMark Colorado Holdings's Clovis Oncology, Inc. position peaked at $23.1M in Q4 2014.
157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2015.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2015, filed 16 Feb 2016.